Report - Cardiovascular Mortality in Patients With Type 2 Diabetes ... · AMINE) trial showed that the dipeptidyl peptidase 4 (DPP-4) inhibitor alogliptin was comparable to placebo on risk

Select PornographicDefamatoryIllegal/UnlawfulSpamOther Terms Of Service ViolationFile a copyright complaint

Please pass captcha verification before submit form